Multiple systematic reviews, meta-analyses, and randomized controlled trials consistently demonstrate that specific therapeutic interventions, including pharmacological treatments like atropine and various optical or light-based modalities, can halt or significantly slow the progression of myopia in children.
The retrieved literature consists of numerous systematic reviews, network meta-analyses, and randomized controlled trials (such as those by IMI, Cochrane living reviews, and recent clinical trials) establishing that various specific optical, pharmacological, and lifestyle interventions effectively slow myopia progression and axial elongation in children. There are no refuting papers, so the verdict is SUPPORTED.